Thomas Collis

[Thomas Collis @BioZip8]

@alphavestcap There is now!! Thanks for the update 🥳

[Thomas Collis @BioZip8]

@alphavestcap There is no record of Royal Assent on March 5

[Thomas Collis @BioZip8]

$NWBO Rare Cancers Bill passed 2/27/26...now set to become Law !!!

[Thomas Collis @BioZip8]

@d_stock07734 God bless you 🙏

[Thomas Collis @BioZip8]

@jascanlan That confirms what I had stated that the CDR was run on 1/10/26. Since that trade on 1/23/26 was "OFF BOOK" the timing of public disclosure is.... Only time will tell for sure

[Thomas Collis @BioZip8]

$NWBO XLOM OFF-BOOK REPORTING VOLUME: 1,564,220 SHARES PRICE: $1.51 USD (€1.31) VENUE: XLOM (LSE OFF-BOOK MTF) DATE/TIME: FRI JAN 23, 2026 (LATE SESSION) Bullish
Jan 25, 2026 8:42 PM

[Thomas Collis @BioZip8]

@jascanlan There was no announcement indicating fictitious data would be in production 1/23-1/26. A CDR was run on Saturday 1/10/26. If you have a Service Announcement you are referring to, please share.

[Thomas Collis @BioZip8]

@jascanlan There was no announcement indicating fictitious data would be in production 1/23-1/26. A CDR was run on Saturday 1/10/26. If you have a Service Announcement you are referring to, please share.

[Thomas Collis @BioZip8]

$NWBO

[Thomas Collis @BioZip8]

$NWBO Rare Cancers Bill Passes Second reading...next step sign it into Law !! https://t.co/KFLb4WRCPU

[Thomas Collis @BioZip8]

$GLYC https://t.co/TCFkuEwV5r

[Thomas Collis @BioZip8]

$GLYC https://t.co/Lw6IqRnIOs

[Oscar Moreno, MD @OscarMorenoMD]

Happy to present at the @VenousForum #VENOUS2023 the results of the first human study on E-Selectin inhibitor #Uproleselan for #COVID19 this Friday! #GlycoMimetics

[Thomas Collis @BioZip8]

$NWBO #CitadelScandal $APE $GME Slap the ask...ALL DAY...EVERY DAY !!! #JUSTICEFORCANCERPATIENTS

[Thomas Collis @BioZip8]

@FlemmingBruce https://t.co/Eyy7xuQRgC

[Thomas Collis @BioZip8]

@sentimentstock @statnews https://t.co/Eyy7xuQRgC

[Thomas Collis @BioZip8]

@apwriter https://t.co/Eyy7xuQRgC

[Thomas Collis @BioZip8]

@drgauravchandra https://t.co/Pz4n8ewdhS

[Thomas Collis @BioZip8]

@biggercapital @CreechTurner @adamfeuerstein BCRX should be added to that list, grossly undervalued due to the short attack. 37 million shorts should burn

[Biotech @ej23ny]

$ATNM early but very promising. Actinium225 phase 1
#astella @BayerUS $NVS $BMY $MRK $PFE $AMGN $ABBV $VRTX